Laboratory of Bacterial Genetics, Centre for DNA Fingerprinting and Diagnostics, Hyderabad 500 001, India.
J Bacteriol. 2011 Nov;193(21):5985-96. doi: 10.1128/JB.05869-11. Epub 2011 Sep 2.
Initially identified as an inhibitor of oriC-initiated DNA replication in vitro, the ArgP or IciA protein of Escherichia coli has subsequently been described as a nucleoid-associated protein and also as a transcriptional regulator of genes involved in DNA replication (dnaA and nrdA) and amino acid metabolism (argO, dapB, and gdhA [the last in Klebsiella pneumoniae]). ArgP mediates lysine (Lys) repression of argO, dapB, and gdhA in vivo, for which two alternative mechanisms have been identified: at the dapB and gdhA regulatory regions, ArgP binding is reduced upon the addition of Lys, whereas at argO, RNA polymerase is trapped at the step of promoter clearance by Lys-bound ArgP. In this study, we have examined promoter-lac fusions in strains that were argP(+) or ΔargP or that were carrying dominant argP mutations in order to identify several new genes that are ArgP-regulated in vivo, including lysP, lysC, lysA, dapD, and asd (in addition to argO, dapB, and gdhA). All were repressed upon Lys supplementation, and in vitro studies demonstrated that ArgP binds to the corresponding regulatory regions in a Lys-sensitive manner (with the exception of argO, whose binding to ArgP was Lys insensitive). Neither dnaA nor nrdA was ArgP regulated in vivo, although their regulatory regions exhibited low-affinity binding to ArgP. Our results suggest that ArgP is a transcriptional regulator for Lys repression of genes in E. coli but that it is noncanonical in that it also exhibits low-affinity binding, without apparent direct regulatory effect, to a number of additional sites in the genome.
最初在体外被鉴定为 oriC 起始 DNA 复制的抑制剂,大肠杆菌的 ArgP 或 IciA 蛋白随后被描述为核基质相关蛋白,也是参与 DNA 复制(dnaA 和 nrdA)和氨基酸代谢(argO、dapB 和 gdhA[在肺炎克雷伯氏菌中])的基因的转录调节剂。ArgP 在体内介导赖氨酸(Lys)对 argO、dapB 和 gdhA 的抑制,为此已经确定了两种替代机制:在 dapB 和 gdhA 调控区,ArgP 结合在添加 Lys 后减少,而在 argO 中,Lys 结合的 ArgP 阻止 RNA 聚合酶在启动子清除步骤中前进。在这项研究中,我们检查了 argP(+)或ΔargP 菌株或携带显性 argP 突变的菌株中的启动子-lac 融合,以鉴定出几种新的体内受 ArgP 调控的基因,包括 lysP、lysC、lysA、dapD 和 asd(除了 argO、dapB 和 gdhA)。所有基因在 Lys 补充时均受到抑制,体外研究表明 ArgP 以 Lys 敏感的方式结合到相应的调控区(argO 除外,其与 ArgP 的结合对 Lys 不敏感)。尽管它们的调控区与 ArgP 具有低亲和力结合,但 dnaA 和 nrdA 在体内均不受 ArgP 调控。我们的结果表明 ArgP 是大肠杆菌中 Lys 抑制基因的转录调节剂,但它是非典型的,因为它还以低亲和力结合,而没有明显的直接调节作用,到基因组中的许多其他位点。